Results at 24 weeks revealed that 76% of individuals achieved a 75% or more improvement in overall disease severity (EASI-75), trial's primary endpoint. Among a study population of adults and ...

Allergies can significantly impair daily activities, school performance, and psychological well-being.

RFK Jr. stated he "couldn't be more pleased" to announce that COVID-19 vaccination among healthy children and pregnant women has been removed from CDC's immunization schedule. "I couldn't be more ...

On May 28, 2025, the FDA approved Eton Pharmaceuticals' new drug application (NDA) for hydrocortisone oral solution (Khindivi) as a replacement therapy for pediatric patients aged 5 years or older ...

Infant is closely monitored at subsequent well visits and rechecked after 3 months, showed full resolution of the skin lesion over the heel area. A healthy 12-month-old girl presented with one small ...

The AI-enabled, wearable device is the first FDA-approved, drug-free solution for nasal congestion and allergies in children ages 12 and up. The FDA has approved an expanded pediatric indication for ...

Our editor-in-chief Tina Tan, MD, reacts to a new FDA COVID-19 framework that will limit eligibility for seasonal vaccination in pediatrics. "Unfortunately, that basically does eliminate access of ...

Colleen Sloan, PA-C, RDN, highlights the connection between poor dietary patterns and mental health challenges in children, and offers nutrient-focused solutions. Colleen Sloan, PA-C, RDN, registered ...

Victor Carrion, MD, explains how providers can recognize the signs of accumulated stress in children and support recovery through education and connection. Victor Carrion, MD, director of the Stanford ...

Aaron Milstone, MD, explains that very low birth weight infants remain disproportionately affected by deadly Staph aureus infections in NICUs. Invasive Staphylococcus aureus infections remain a major ...

A recently published study found sharp increase in the use of nicotine pouches among US high school students, with usage nearly doubling from 2023 to 2024. A recent study conducted by researchers from ...

With the new drug application accepted with priority review, the FDA has assigned a date of November 20, 2025, to complete its review for potential approval. On June 2, 2025, the FDA accepted a new ...